ACTCerebra identifies targeted drug options for brain metastases


Brain metastases occur when cancer cell travel to brain via blood vessels in late-stage, and certain amount of cancer patients will develop brain metastases especially lung and breast cancer. The advance of cancer treatment enables higher chances for long-term survival, however the risk of brain metastases development also increases, which makes the treatment for brain metastases highly valued.

Surgery, radiation therapy, and chemotherapy are mostly used to treat brain metastases as a result of the inadequate brain penetration of targeted therapy. ACTCerebra, ACT Genomics’ latest genomic profiling service, sequences 40 druggable genes to create a new opportunity for physicians to identify the most effective targeted therapies based on past medical history.